
The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using CSB-PA063322(AMZ2 Antibody) at dilution 1/40, on the right is treated with fusion protein. (Original magnification: x200)
AMZ2 Antibody
CSB-PA063322
ApplicationsELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetAMZ2
Overview
- SupplierCusabio
- Product NameAMZ2 Antibody
- Delivery Days Customer20
- ApplicationsELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID51321
- Target nameAMZ2
- Target descriptionarchaelysin family metallopeptidase 2
- Target synonymsarchaemetzincin-2, archaemetzincins-2, archeobacterial metalloproteinase-like protein 2
- HostRabbit
- IsotypeIgG
- Protein IDQ86W34
- Protein NameArchaemetzincin-2
- Scientific DescriptionAMZ2 (archaelysin family metallopeptidase 2), also known as archaemetzincin-2 or archeobacterial metalloproteinase-like protein 2, is a 360 amino acid protein belonging to the peptidase M54 family. Encoded by a gene that maps to human chromosome 17q24.2, AMZ2 is predominantly expressed in heart and testis. AMZ2 is also expressed in kidney, liver, pancreas, lung, brain and placenta, and in fetal tissues such as kidney, liver, lung and brain. AMZ2 participates in metal ion binding and functions as a zinc metalloprotease. AMZ2 is inhibited by both general metalloprotease inhibitors o-phenanthroline and batimastat. Exhibiting aminopeptidase activity, AMZ2 acts against Angiotensin in vitro, but does not hydrolyze either Neurogranin or Angiotensin.
- ReactivityHuman
- Storage Instruction-20°C or -80°C
- UNSPSC41116161




